Home Newsfeeds Craig-Hallum Maintains Buy on Transcat, Raises Price Target to $92

Craig-Hallum Maintains Buy on Transcat, Raises Price Target to $92

Craig-Hallum analyst Greg Palm maintains Transcat (NASDAQ:TRNS) with a Buy and raises the price target from $81 to $92.

byBenzinga Newsdesk

February 1, 2023

1 minute read

Craig-Hallum analyst Greg Palm maintains Transcat (NASDAQ:TRNS) with a Buy and raises the price target from $81 to $92.

Fresh Vine Wine, Inc. Announces Subscriptions Of ~$3.14M From Its Rights Offering

By Happy Mohamed

March 10, 9:33 AM

Fresh Vine Wine, Inc. (NYSE:VINE) ("Fresh Vine Wine" or the "Company"), a premier producer of lower carb, lower calorie premium wines in the United States, today announced the preliminary results of

VINE

News

NRx Receives Nasdaq Notice of Listing Compliance

By Benzinga Newsdesk

December 2, 7:48 AM

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced it received written notice on December 1,

NRXP

Nordstrom Sees FY23 Revenue Decline, Including Retail Sales And Credit Card Revenues, Of 4%-6% Versus FY22, Including An ~ 250 Basis Point Negative Impact From The Wind-Down Of Canadian Operations And An ~ 130 Basis Point Positive Impact From The 53rd…

By Benzinga Newsdesk

November 21, 5:07 PM

FISCAL YEAR 2023 OUTLOOK The Company updated its financial outlook for fiscal 2023, which includes a 53rd week and reflects the true-up related to the wind-down of Canadian operations and related tax impacts recorded in the third quarter:

JWN